10-Q 1 bbrw-10q.htm FORM 10-Q
0001641751 false --12-31 2022 Q3 2473922 P4D P1Y P2Y8M19D P5Y 2025-06-18 2026-01-05 2026-01-05 2026-07-15 2026-07-15 2026-09-14 2026-09-14 2027-08-08 P4Y5M5D P4Y9M29D P5Y 0001641751 2022-01-01 2022-09-30 0001641751 2022-11-07 0001641751 2022-09-30 0001641751 2021-12-31 0001641751 us-gaap:SeriesAPreferredStockMember 2022-09-30 0001641751 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001641751 us-gaap:SeriesBPreferredStockMember 2022-09-30 0001641751 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001641751 2022-07-01 2022-09-30 0001641751 2021-07-01 2021-09-30 0001641751 2021-01-01 2021-09-30 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001641751 bbrw:ConvertiblePreferredStockSharesPayableMember 2021-12-31 0001641751 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-12-31 0001641751 us-gaap:CommonStockMember 2021-12-31 0001641751 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001641751 us-gaap:RetainedEarningsMember 2021-12-31 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2020-12-31 0001641751 bbrw:ConvertiblePreferredStockSharesPayableMember 2020-12-31 0001641751 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2020-12-31 0001641751 us-gaap:CommonStockMember 2020-12-31 0001641751 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001641751 us-gaap:RetainedEarningsMember 2020-12-31 0001641751 2020-12-31 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-03-31 0001641751 bbrw:ConvertiblePreferredStockSharesPayableMember 2022-01-01 2022-03-31 0001641751 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-03-31 0001641751 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001641751 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001641751 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001641751 2022-01-01 2022-03-31 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2022-04-01 2022-06-30 0001641751 bbrw:ConvertiblePreferredStockSharesPayableMember 2022-04-01 2022-06-30 0001641751 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-04-01 2022-06-30 0001641751 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001641751 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001641751 2022-04-01 2022-06-30 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2022-07-01 2022-09-30 0001641751 bbrw:ConvertiblePreferredStockSharesPayableMember 2022-07-01 2022-09-30 0001641751 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-07-01 2022-09-30 0001641751 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001641751 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2021-01-01 2021-03-31 0001641751 bbrw:ConvertiblePreferredStockSharesPayableMember 2021-01-01 2021-03-31 0001641751 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-01-01 2021-03-31 0001641751 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001641751 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001641751 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001641751 2021-01-01 2021-03-31 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2021-04-01 2021-06-30 0001641751 bbrw:ConvertiblePreferredStockSharesPayableMember 2021-04-01 2021-06-30 0001641751 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-04-01 2021-06-30 0001641751 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001641751 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001641751 2021-04-01 2021-06-30 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2021-07-01 2021-09-30 0001641751 bbrw:ConvertiblePreferredStockSharesPayableMember 2021-07-01 2021-09-30 0001641751 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-07-01 2021-09-30 0001641751 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001641751 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2022-03-31 0001641751 bbrw:ConvertiblePreferredStockSharesPayableMember 2022-03-31 0001641751 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-03-31 0001641751 us-gaap:CommonStockMember 2022-03-31 0001641751 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001641751 us-gaap:RetainedEarningsMember 2022-03-31 0001641751 2022-03-31 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2022-06-30 0001641751 bbrw:ConvertiblePreferredStockSharesPayableMember 2022-06-30 0001641751 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-06-30 0001641751 us-gaap:CommonStockMember 2022-06-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001641751 us-gaap:RetainedEarningsMember 2022-06-30 0001641751 2022-06-30 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2022-09-30 0001641751 bbrw:ConvertiblePreferredStockSharesPayableMember 2022-09-30 0001641751 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-09-30 0001641751 us-gaap:CommonStockMember 2022-09-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001641751 us-gaap:RetainedEarningsMember 2022-09-30 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2021-03-31 0001641751 bbrw:ConvertiblePreferredStockSharesPayableMember 2021-03-31 0001641751 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-03-31 0001641751 us-gaap:CommonStockMember 2021-03-31 0001641751 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001641751 us-gaap:RetainedEarningsMember 2021-03-31 0001641751 2021-03-31 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2021-06-30 0001641751 bbrw:ConvertiblePreferredStockSharesPayableMember 2021-06-30 0001641751 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-06-30 0001641751 us-gaap:CommonStockMember 2021-06-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001641751 us-gaap:RetainedEarningsMember 2021-06-30 0001641751 2021-06-30 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2021-09-30 0001641751 bbrw:ConvertiblePreferredStockSharesPayableMember 2021-09-30 0001641751 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-09-30 0001641751 us-gaap:CommonStockMember 2021-09-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001641751 us-gaap:RetainedEarningsMember 2021-09-30 0001641751 2021-09-30 0001641751 2021-01-01 2021-12-31 0001641751 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001641751 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001641751 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeMember 2022-09-30 0001641751 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeMember 2021-12-31 0001641751 us-gaap:ComputerEquipmentMember 2022-09-30 0001641751 us-gaap:ComputerEquipmentMember 2021-12-31 0001641751 us-gaap:LeaseholdImprovementsMember 2022-09-30 0001641751 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001641751 us-gaap:MachineryAndEquipmentMember 2022-09-30 0001641751 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001641751 us-gaap:SoftwareDevelopmentMember 2022-09-30 0001641751 us-gaap:SoftwareDevelopmentMember 2021-12-31 0001641751 us-gaap:VehiclesMember 2022-09-30 0001641751 us-gaap:VehiclesMember 2021-12-31 0001641751 bbrw:EighteenHundredDiagonalLending1Member 2022-09-30 0001641751 bbrw:EighteenHundredDiagonalLending1Member 2022-01-01 2022-09-30 0001641751 bbrw:EighteenHundredDiagonalLending1Member 2021-12-31 0001641751 bbrw:EighteenHundredDiagonalLending2Member 2022-09-30 0001641751 bbrw:EighteenHundredDiagonalLending2Member 2022-01-01 2022-09-30 0001641751 bbrw:EighteenHundredDiagonalLending2Member 2021-12-31 0001641751 bbrw:CBP3Member 2022-09-30 0001641751 bbrw:CBP3Member 2022-01-01 2022-09-30 0001641751 bbrw:CBP3Member 2021-12-31 0001641751 bbrw:CBP4Member 2022-09-30 0001641751 bbrw:CBP4Member 2022-01-01 2022-09-30 0001641751 bbrw:CBP4Member 2021-12-31 0001641751 bbrw:EmergingCorpCapital2Member 2022-09-30 0001641751 bbrw:EmergingCorpCapital2Member 2022-01-01 2022-09-30 0001641751 bbrw:EmergingCorpCapital2Member 2021-12-31 0001641751 bbrw:GPLVentures3Member 2022-09-30 0001641751 bbrw:GPLVentures3Member 2022-01-01 2022-09-30 0001641751 bbrw:GPLVentures3Member 2021-12-31 0001641751 bbrw:MammothCorp1Member 2022-09-30 0001641751 bbrw:MammothCorp1Member 2022-01-01 2022-09-30 0001641751 bbrw:MammothCorp1Member 2021-12-31 0001641751 bbrw:MammothCorp2Member 2022-09-30 0001641751 bbrw:MammothCorp2Member 2022-01-01 2022-09-30 0001641751 bbrw:MammothCorp2Member 2021-12-31 0001641751 bbrw:MammothCorp3Member 2022-09-30 0001641751 bbrw:MammothCorp3Member 2022-01-01 2022-09-30 0001641751 bbrw:MammothCorp3Member 2021-12-31 0001641751 bbrw:MastHillFund1Member 2022-09-30 0001641751 bbrw:MastHillFund1Member 2022-01-01 2022-09-30 0001641751 bbrw:MastHillFund1Member 2021-12-31 0001641751 bbrw:MastHillFund2Member 2022-09-30 0001641751 bbrw:MastHillFund2Member 2022-01-01 2022-09-30 0001641751 bbrw:MastHillFund2Member 2021-12-31 0001641751 bbrw:Optempus1Member 2022-09-30 0001641751 bbrw:Optempus1Member 2022-01-01 2022-09-30 0001641751 bbrw:Optempus1Member 2021-12-31 0001641751 bbrw:Optempus2Member 2022-09-30 0001641751 bbrw:Optempus2Member 2022-01-01 2022-09-30 0001641751 bbrw:Optempus2Member 2021-12-31 0001641751 bbrw:Optempus3Member 2022-09-30 0001641751 bbrw:Optempus3Member 2022-01-01 2022-09-30 0001641751 bbrw:Optempus3Member 2021-12-31 0001641751 bbrw:Optempus4Member 2022-09-30 0001641751 bbrw:Optempus4Member 2022-01-01 2022-09-30 0001641751 bbrw:Optempus4Member 2021-12-31 0001641751 bbrw:PowerUpLending23Member 2022-09-30 0001641751 bbrw:PowerUpLending23Member 2022-01-01 2022-09-30 0001641751 bbrw:PowerUpLending23Member 2021-12-31 0001641751 bbrw:PowerUpLending24Member 2022-09-30 0001641751 bbrw:PowerUpLending24Member 2022-01-01 2022-09-30 0001641751 bbrw:PowerUpLending24Member 2021-12-31 0001641751 bbrw:PowerUpLending25Member 2022-09-30 0001641751 bbrw:PowerUpLending25Member 2022-01-01 2022-09-30 0001641751 bbrw:PowerUpLending25Member 2021-12-31 0001641751 bbrw:TriBridge3Member 2022-09-30 0001641751 bbrw:TriBridge3Member 2022-01-01 2022-09-30 0001641751 bbrw:TriBridge3Member 2021-12-31 0001641751 bbrw:TriBridge4Member 2022-09-30 0001641751 bbrw:TriBridge4Member 2022-01-01 2022-09-30 0001641751 bbrw:TriBridge4Member 2021-12-31 0001641751 bbrw:TriBridge5Member 2022-09-30 0001641751 bbrw:TriBridge5Member 2022-01-01 2022-09-30 0001641751 bbrw:TriBridge5Member 2021-12-31 0001641751 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-09-30 0001641751 bbrw:ConvertibleNotesPayable1Member 2021-01-05 0001641751 bbrw:ConvertibleNotesPayable1Member 2021-01-04 2021-01-05 0001641751 bbrw:ConvertibleNotesPayable1Member 2022-01-01 2022-09-30 0001641751 bbrw:ConvertibleNotesPayable1Member 2022-09-30 0001641751 bbrw:ConvertibleNotesPayable2Member 2021-07-15 0001641751 bbrw:ConvertibleNotesPayable2Member 2021-07-14 2021-07-15 0001641751 bbrw:ConvertibleNotesPayable2Member 2022-01-01 2022-09-30 0001641751 bbrw:ConvertibleNotesPayable2Member 2022-09-30 0001641751 bbrw:ConvertibleNotesPayable3Member 2021-09-14 0001641751 bbrw:ConvertibleNotesPayable3Member 2021-09-13 2021-09-14 0001641751 bbrw:ConvertibleNotesPayable3Member 2022-01-01 2022-09-30 0001641751 bbrw:ConvertibleNotesPayable3Member 2022-09-30 0001641751 bbrw:ConvertibleNotesPayable4Member 2022-06-09 0001641751 bbrw:ConvertibleNotesPayable4Member 2022-06-09 2022-06-09 0001641751 bbrw:ConvertibleNotesPayable4Member 2022-01-01 2022-09-30 0001641751 bbrw:ConvertibleNotesPayable4Member 2022-09-30 0001641751 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-09-30 0001641751 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001641751 us-gaap:ConvertibleDebtSecuritiesMember 2021-12-31 0001641751 us-gaap:WarrantMember 2021-12-31 0001641751 us-gaap:ConvertibleDebtSecuritiesMember 2022-09-30 0001641751 us-gaap:WarrantMember 2022-09-30 0001641751 us-gaap:ConvertibleDebtSecuritiesMember srt:MinimumMember 2022-01-01 2022-09-30 0001641751 us-gaap:ConvertibleDebtSecuritiesMember srt:MaximumMember 2022-01-01 2022-09-30 0001641751 us-gaap:WarrantMember srt:MinimumMember 2022-01-01 2022-09-30 0001641751 us-gaap:WarrantMember srt:MaximumMember 2022-01-01 2022-09-30 0001641751 bbrw:Warrant1Member 2022-09-30 0001641751 bbrw:Warrant1Member 2022-01-01 2022-09-30 0001641751 bbrw:Warrant2Member 2022-09-30 0001641751 bbrw:Warrant2Member 2022-01-01 2022-09-30 0001641751 bbrw:Warrant3Member 2022-09-30 0001641751 bbrw:Warrant3Member 2022-01-01 2022-09-30 0001641751 bbrw:Warrant4Member 2022-09-30 0001641751 bbrw:Warrant4Member 2022-01-01 2022-09-30 0001641751 bbrw:Warrant5Member 2022-09-30 0001641751 bbrw:Warrant5Member 2022-01-01 2022-09-30 0001641751 bbrw:Warrant6Member 2022-09-30 0001641751 bbrw:Warrant6Member 2022-01-01 2022-09-30 0001641751 bbrw:Warrant7Member 2022-09-30 0001641751 bbrw:Warrant7Member 2022-01-01 2022-09-30 0001641751 bbrw:Warrant8Member 2022-09-30 0001641751 bbrw:Warrant8Member 2022-01-01 2022-09-30 0001641751 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001641751 bbrw:ConsultantAgreementMember bbrw:Director1Member 2022-01-01 2022-09-30 0001641751 bbrw:Director1Member 2021-12-31 0001641751 bbrw:Director1Member 2022-09-30 0001641751 2021-08-01 2021-08-31 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2019-07-01 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember bbrw:DistributionAndLicensingAgreementsMember 2020-04-05 2020-04-06 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember bbrw:IPPurchaseAndLicensingAgreementsMember 2020-04-05 2020-04-06 0001641751 us-gaap:CommonStockMember 2020-11-19 2020-11-20 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2020-11-19 2020-11-20 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2020-01-01 2020-12-31 0001641751 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember bbrw:Director2Member 2020-12-30 2021-01-02 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember bbrw:KeyEmployee1Member 2021-04-12 2021-04-13 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember bbrw:KeyEmployee2Member 2021-04-12 2021-04-13 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2021-05-13 2021-05-14 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember bbrw:Director2Member 2021-09-13 2021-09-15 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember bbrw:Director2Member 2021-11-30 2021-12-01 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember srt:ManagementMember 2021-12-07 2021-12-08 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember bbrw:Director1Member 2021-12-26 2021-12-27 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2021-01-01 2021-12-31 0001641751 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember bbrw:EmployeeAndrewSaloMember 2022-03-01 2022-03-02 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember bbrw:JefFreemanMember 2022-03-04 2022-03-04 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2022-06-09 2022-06-09 0001641751 us-gaap:CommonStockMember 2022-06-09 2022-06-09 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember bbrw:IPPurchaseAndLicensingAgreementsMember 2022-06-10 2022-06-10 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember bbrw:IPPurchaseAndLicensingAgreementsMember 2022-06-10 0001641751 bbrw:ConvertiblePreferredStocksMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-09-30 0001641751 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001641751 us-gaap:SeriesBPreferredStockMember 2017-03-28 0001641751 us-gaap:SeriesBPreferredStockMember 2017-03-27 2017-03-28 0001641751 us-gaap:SeriesBPreferredStockMember srt:ManagementMember 2019-11-22 0001641751 us-gaap:CommonStockMember 2020-03-16 2020-03-17 0001641751 2020-01-01 2020-12-31 0001641751 2020-03-24 0001641751 2020-03-25 0001641751 2020-12-03 0001641751 2020-12-04 0001641751 2021-06-09 0001641751 2021-06-10 0001641751 2022-04-20 2022-04-20 0001641751 2022-04-19 0001641751 2022-04-20 0001641751 2022-04-25 0001641751 2022-04-26 0001641751 2022-06-09 2022-06-09 0001641751 2022-07-20 0001641751 2022-07-21 0001641751 2019-12-30 2020-01-02 0001641751 2019-01-02 0001641751 2020-01-01 2020-01-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure
 

 

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q

 

Mark One

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2022

 

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______ to _______

 

Commission file number 000-55787

 

BrewBilt Manufacturing Inc.
(Exact name of registrant as specified in its charter)

 

(BREWBILT MANUFACTURING LOGO)

 

Florida       47-0990750
(State or other
jurisdiction of incorporation)
      (I.R.S. Employer
Identification No.)
         

110 Spring Hill Road #10
Grass Valley, CA 95945

(Address of principal executive offices)

 

(530) 802-5023
(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

  Yes  x No  o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files

 

  Yes  x No  o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer o Accelerated filer o
Non-accelerated Filer o (Do not check if a smaller reporting company) Smaller reporting company x
  Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

  Yes  o No  x

 

As of November 7, 2022, there were 788,743,081 shares of the registrant’s $0.001 par value common stock issued and outstanding.

 

 

CONTENTS

 

    Page
  PART I – FINANCIAL INFORMATION  
     
Item 1. Financial Statements 3
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 25
     
Item 3. Quantitative and Qualitative Disclosure about Market Risk 28
     
Item 4. Controls and Procedures 28
     
  PART II – OTHER INFORMATION  
     
Item 1. Legal Proceedings 29
     
Item 1A. Risk Factors 29
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 29
     
Item 3. Defaults Upon Senior Securities 29
     
Item 4. Mine Safety Disclosures 29
     
Item 5. Other Information 29
     
Item 6. Exhibits 30
     
  SIGNATURES 31

 

FORWARD LOOKING STATEMENTS

 

Statements made in this Form 10-Q that are not historical or current facts are “forward-looking statements.”. These statements often can be identified by the use of terms such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “approximate” or “continue,” or the negative thereof. We intend that such forward-looking statements be subject to the safe harbors for such statements. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management’s best judgment as to what may occur in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events.

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions for Form 10-Q and Article 210 8-03 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal recurring nature. Operating results for the nine months ended September 30, 2022, are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. For further information, refer to the financial statements and footnotes thereto included in our company’s Annual Report on Form 10-K for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on March 31, 2022.

 

REPORTED IN UNITED STATES DOLLARS

 

  Page
Balance Sheets (Unaudited) 5
Statements of Operations and Comprehensive Loss (Unaudited) 7
Statements of Shareholders’ Deficit (Unaudited) 8
Statements of Cash Flows (Unaudited) 10
Notes to Financial Statements 12-28

3

 

 

BREWBILT MANUFACTURING INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

 

   September 30,   December 31, 
   2022   2021 
ASSETS    (unaudited)      (audited)  
Current Assets          
Cash  $37,955   $219,183 
Accounts receivable   275,647    3,495 
Earnings in excess of billings   699,853    880,494 
Inventory   186,836    147,859 
Prepaid expenses   1,005,749    48,217 
Other current assets       19,500 
Total current assets   2,206,040    1,318,748 
           
Property, plant, and equipment, net   208,308    249,208 
Intangibles, net   425,000    500,000 
Right-of-use asset   169,805    203,991 
Security deposit   16,980    16,980 
Other assets   1,085,305    85,305 
           
TOTAL ASSETS  $4,111,438   $2,374,232 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current Liabilities:          
Accounts payable  $617,451   $640,428 
Accrued interest   232,449    206,806 
Accrued liabilities   235,229    119,090 
Billings in excess of revenue   1,235,438    1,104,923 
Current operating lease liabilities   48,350    45,970 
Convertible notes payable, net of discount   958,820    910,062 
Derivative liabilities   616,318    882,706 
Liability for unissued shares   150,825    150,825 
Promissory notes payable, net of discount   404,288    205,815 
Related party liabilities   180,794    138,029 
Total Current Liabilities   4,679,962    4,404,654 
           
Long term debt   144,200    152,390 
Non-current operating lease liabilities   121,455    158,021 
           
Total Liabilities   4,945,617    4,715,065 
           
Series A convertible preferred stock: $0.001 par value; 30,000,000 shares authorized 1,364,052 shares issued and outstanding at September 30, 2022 1,329,717 shares issued and outstanding at December 31, 2021   13,640,520    13,297,170 
Convertible preferred stock payable   166,000    500,000 
           
Commitments and contingencies        
           
Stockholders’ Deficit:          
Preferred stock, Series B: $0.001 par value; 1,000 shares authorized 1,000 shares issued and outstanding at September 30, 2022 1,000 shares issued and outstanding at December 31, 2021   1    1 
Common stock, $0.001 par value; 15,000,000,000 authorized 635,971,617 shares issued and outstanding at September 30, 2022 (1) 27,031,772 shares issued and outstanding at December 31, 2021 (1)   635,972    27,032 
Additional paid in capital   7,463,429    2,488,366 
Retained earnings   (22,740,101)   (18,653,402)
Total stockholders’ deficit   (14,640,699)   (16,138,003)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT  $4,111,438   $2,374,232 

 

(1)Common share amounts and per share amounts in the financial statements reflect the one-for-three hundred reverse stock split that was made effective on April 28, 2022.

 

The accompanying notes are an integral part of these financial statements

4

 

BREWBILT MANUFACTURING INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(Unaudited)

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2022   2021   2022   2021 
Sales  $118,219   $575,128   $1,102,141   $637,143 
Cost of sales   79,455    357,429    778,325    373,544 
Gross profit   38,764    217,699    323,816    263,599 
                     
Operating expenses:                    
Consulting fees   28,500    (67,500)   175,500    78,531 
Depreciation and amortization   11,028    11,591    40,900    30,691 
G&A expenses   153,724    170,477    518,409    445,573 
Professional fees   26,249    22,903    56,925    137,961 
Salaries and wages   163,793    112,441    610,184    421,229 
Total operating expenses   383,294    249,912    1,401,918    1,113,985 
                     
Loss from operations   (344,530)   (32,213)   (1,078,102)   (850,386)
                     
Other income (expense):                    
Other income   1    3    3    25,007 
Gain on debt settlement           22,029     
Gain on debt forgiveness   51,756        51,756    75,512 
Derivative expenses   1,035,866    (792,182)   (767,059)   (1,395,887)
Loss on conversion of debt   (31,456)       (1,052,852)   (457,681)
Loss on Series A conversion   (35,702)   (262,778)   (145,572)   (1,845,926)
Loss on disposal of assets       (16,267)       (16,267)
Interest expense   (377,984)   (415,441)   (1,116,902)   (1,251,175)
Total other expenses   642,481    (1,486,665)   (3,008,597)   (4,866,417)
                     
Net profit (loss) before income taxes   297,951    (1,518,878)   (4,086,699)   (5,716,803)
Income tax expense                
Net profit (loss)  $297,951   $(1,518,878)  $(4,086,699)  $(5,716,803)
                     
Per share information                    
Weighted number of common shares outstanding, basic and diluted (1)   338,623,370    20,065,897    158,378,671    16,563,647 
Net profit (loss) per common share  $0.0009   $(0.0757)  $(0.0258)  $(0.3451)

 

(1)Common share amounts and per share amounts in the financial statements reflect the one-for-three hundred reverse stock split that was made effective on April 28, 2022.

 

The accompanying notes are an integral part of these financial statements

5

 

BREWBILT MANUFACTURING INC.
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’ EQUITY (DEFICIT)
(Unaudited)

 

   Convertible Preferred Stock   Preferred Stock           Additional   Retained   Total 
   Series A   Shares   Series B   Common Stock   Paid-In   Earnings   Shareholders’ 
   Shares   Amount   Payable   Shares   Amount   Shares (1)   Amount   Capital   (Deficit)   Equity (Deficit) 
Balance at December 31, 2021   1,329,717   $13,297,170   $500,000    1,000   $1    27,031,772   $27,032   $2,488,366   $(18,653,402)  $(16,138,003)
Conversion of convertible notes payable to stock                       12,615,733    12,616    1,329,400        1,342,016 
Derivative settlements                               521,712        521,712 
Preferred stock converted to common stock   (23,720)   (237,200)               3,029,934    3,030    355,727        358,757 
Preferred stock issued for services   7,500    75,000                                 
Preferred stock payable converted to convertible preferred stock   50,000    500,000    (500,000)                            
Preferred shares to be issued for services           150,000                             
Net loss                                   (2,074,089)   (2,074,089)
Balance at March 31, 2022   1,363,497   $13,634,970   $150,000    1,000   $1    42,677,439   $42,678   $4,695,205   $(20,727,491)  $(15,989,607)
                                                   
Conversion of convertible notes payable to stock                       7,905,611    7,906    85,033        92,939 
Derivative settlements                               215,935        215,935 
Preferred stock converted to common stock   (205,185)   (2,051,850)               206,435,537    206,435    1,833,730        2,040,165 
Common stock issued per agreement                       4,000,000    4,000    36,000        40,000 
Preferred stock issued to settle debt   10,500    105,000                                 
Preferred stock issued for future advertising expenses   200,000    2,000,000                                 
Rounding due to reverse stock split                       8,062    8    (8)        
Net loss                                   (2,310,561)   (2,310,561)
Balance at June 30, 2022   1,368,812   $13,688,120   $150,000    1,000   $1    261,026,649   $261,027   $6,865,895   $(23,038,052)  $(15,911,129)
                                                   
Conversion of convertible notes payable to stock                       319,588,942    319,589    23,442        343,031 
Derivative settlements                               546,148        546,148 
Preferred stock converted to common stock   (4,760)   (47,600)               11,900,000    11,900    71,400        83,300 
Common stock cancelled                       (60,000)   (60)   60         
Preferred shares to be issued for services           16,000                             
Cashless warrant exercise                       43,516,026    43,516    (43,516)        
Net loss                                   297,951    297,951 
Balance at September 30, 2022   1,364,052   $13,640,520   $166,000    1,000   $1    635,971,617   $635,972   $7,463,429   $(22,740,101)  $(14,640,699)
                                                   
   Convertible Preferred Stock   Preferred Stock           Additional   Retained   Total 
   Series A   Shares   Series B   Common Stock   Paid-In   Earnings   Shareholders’ 
   Shares   Amount   Payable   Shares   Amount   Shares   Amount   Capital   (Deficit)   Equity (Deficit) 
Balance at December 31, 2020   1,120,000   $11,200,000   $    1,000   $1    11,780,075   $11,780   $(8,424,892)  $(6,956,293)  $(15,369,404)
Conversion of convertible notes payable to stock                       583,535    584    1,622,752        1,623,336 
Derivative settlements                               435,301        435,301 
Preferred stock converted to common stock   (172,500)   (1,725,000)               1,900,998    1,901    2,509,414        2,511,315 
Preferred stock issued for services   10,000    100,000                                 
Warrant exercise                       240,162    240    (240)        
Net loss                                   (2,637,758)   (2,637,758)
Balance at March 31, 2021   957,500   $9,575,000   $    1,000   $1    14,504,770   $14,505   $(3,857,665)  $(9,594,051)  $(13,437,210)
                                                   
Conversion of convertible notes payable to stock                       1,104,722    1,105    996,789        997,894 
Conversion of promissory notes to stock                       660,435    660    593,731        594,391 
Derivative settlements                               (476,872)       (476,872)
Preferred stock converted to common stock   (112,500)   (1,125,000)               1,932,519    1,933    1,919,900        1,921,833 
Preferred stock issued for services   20,000    200,000                                 
Preferred stock issued to settle debt   14,497    144,970                                 
Net loss                                   (1,560,167)   (1,560,167)
Balance at June 30, 2021   879,497   $8,794,970   $    1,000   $1    18,202,446   $18,203   $(824,117)  $(11,154,218)  $(11,960,131)
                                                   
Conversion of convertible notes payable to stock                       1,158,340    1,158    646,155        647,313 
Derivative settlements                               (132,670)       (132,670)
Preferred stock converted to common stock   (72,500)   (725,000)               2,100,218    2,100    985,677        987,777 
Preferred stock cancelled for services   (10,000)   (100,000)                                
Net loss                                   (1,518,878)   (1,518,878)
Balance at September 30, 2021   796,997   $7,969,970   $    1,000   $1    21,461,004   $21,461   $675,045   $(12,673,096)  $(11,976,589)

 

(1)Common share amounts and per share amounts in the financial statements reflect the one-for-three hundred reverse stock split that was made effective on April 28, 2022.

 

The accompanying notes are an integral part of these financial statements

6

 

BREWBILT MANUFACTURING INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

 

   Nine months ended 
   September 30, 
   2022   2021 
Cash flows from operating activities:          
Net loss  $(4,086,699)  $(5,716,803)
Adjustments to reconcile net income to net cash provided by operating activities:          
Amortization of convertible debt discount   864,933    1,089,415 
Amortization of capitalized distribution fees   75,000     
Change in derivative liability   767,059    1,395,887 
Preferred stock issued for services   25,000    200,000 
Preferred stock issued for advertising expenses   2,000,000     
Gain on debt settlement   (22,029)    
Gain on debt forgiveness   (51,756)   (75,512)
Depreciation and amortization of fixed assets   40,900    30,691 
Loss on debt conversion   1,052,852    457,681 
Loss on Series A conversion   145,572    1,845,926 
Penalties on debt settlement and debt conversion   66,488     
Share based compensation   256,000     
Decrease (increase) in operating assets          
Accounts receivable   (272,152)   (1,064,112)
Earnings in excess of billings   180,641    (598,231)
Inventory   (38,977)   (198,293)
Prepaid expenses   (957,532)   (83,937)
Other assets   (980,500)   (19,500)
Increase (decrease) in operating liabilities          
Accounts payable   (22,977)   98,696 
Accrued interest   174,032    148,968 
Accrued liabilities   116,139    (101,531)
Billings in excess of revenues   130,515    1,958,291 
Net cash (used in) provided by operating activities   (537,491)   (632,364)
           
Cash flows from investing activities          
Property, plant and equipment, additions       (247,050)
Property, plant and equipment, reductions       90,746 
Net cash (used in) provided by investing activities       (156,304)
           
Cash flows from financing activities:          
Long term debt   (8,190)   (130,748)
Payments on convertible debt   (157,632)    
Proceeds from convertible debt   309,320    942,000 
Proceeds from promissory notes   170,000    184,000 
Related party liabilities   42,765    (3,548)
Net cash (used in) provided for financing activities   356,263    991,704 
           
Net increase (decrease) in cash   (181,228)   203,036 
           
Cash, beginning of period   219,183    72,764 
Cash, end of period  $37,955   $275,800 
           
Supplemental disclosures of cash flow information:          
Cash paid for income taxes  $   $ 
Cash paid for interest  $   $ 
           
Schedule of non-cash investing & financing activities          
Stock issued for note payable conversion  $1,777,986   $3,268,543 
Stock issued for promissory note conversion  $   $594,391 
Derivative settlements  $1,283,795   $(174,241)
Discount from derivative  $250,348   $1,168,578 
Preferred stock converted to common stock  $2,482,222   $5,420,925 
Preferred stock issued to settle liabilities  $105,000   $144,970 
Cashless warrant exercise  $43,516   $240 
Rounding due to stock split  $8   $ 

 

(1)Common share amounts and per share amounts in the financial statements reflect the one-for-three hundred reverse stock split that was made effective on April 28, 2022.

 

The accompanying notes are an integral part of these financial statements

7

 

BREWBILT MANUFACTURING INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2022
(unaudited)

 

1 – BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Organization and Description of Business

 

Located in Grass Valley, CA, BrewBilt is one of the only California companies that custom designs, hand crafts, and integrates brewing, fermentation and distilling systems for the craft beer industry using “Best in Class” American made stainless steel. Founded by Jeff Lewis in 2014 with a vision of creating a profitable company by hiring excellent local craftsmen, designing and building products to exceed customers’ expectations Mr. Lewis now has over 20 years of experience as a craft beer brewer, a custom tank/vessel designer, fabrication and integration expert and business owner who initially founded Portland Kettle Works.

 

BrewBilt has strong relationships with suppliers of raw materials, equipment, and services globally, in addition an aggressive referral network of satisfied customers nationwide. An Advisory Board consisting of successful business leaders that provide valuable product feedback and business expertise to management. The craft brewing & spirits industries continue to grow worldwide. California is where craft brewing began and now has over 950 operating breweries – being centrally located in this booming market was a large draw for BrewBilt to locate its manufacturing facility in the Sierra foothills.

 

All BrewBilt products are designed and fabricated as “food grade” quality which enables the company to build vessels for food and beverage processing. BrewBilt buys materials and components mostly from suppliers which enables BrewBilt to closely monitor quality, while the company’s revenues are generated from sales to customers throughout the world a great deal of specific interest in coming from Mexico, Japan, Europe, and Australia.

 

In July of 2016, BrewBilt moved from the small facility in Nevada City, CA to lease an eight thousand (8,000) square foot manufacturing facility in Grass Valley, CA. This facility was purchased by BrewBilt in January 2018 and upgraded with substantial tenant improvements. BrewBilt obtains the majority of its leads through customer referrals and from online marketplaces. The company’s website has expanded to include online sales and online educational/marketing videos that feature the company and its expanded product line of brewing accessories. BrewBilt has also created distribution sales agreements with individuals and companies to represent BrewBilt in both the domestic and international markets.

 

On April 20, 2022, the Company approved the authorization of a one for three hundred reverse stock split of the Company’s outstanding shares of common stock. The reverse split was effective on April 28, 2022, and the financial statements have been retroactively adjusted to take this into account for all periods presented. The Company issued 8,062 common shares due to rounding in connection with the reverse stock split.

 

Amendments to Previously Reported Annual Financial Information

 

The Company’s previously issued financial statements for the nine months ended September 30, 2021, as included in its Form 10-Q filed on November 15, 2021, have been restated since the Company improperly classified the Series A preferred stock in permanent equity as opposed to liability pursuant to ASC 480-10-25-14(A), since the financial instrument embodies an unconditional obligation to transfer a variable number of shares and the monetary value of such obligation is based solely on a fixed amount known at inception.

 

Financial Statement Presentation

 

The audited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

 

8

 

Business Combinations

 

As per ASC 805-50 a common-control transaction does not meet the definition of a business combination because there is no change in control over the net assets. The accounting for these transactions is addressed in the “Transactions Between Entities Under Common Control”. The net assets are derecognized by the transferring entity and recognized by the receiving entity at the historical cost of the parent of the entities under common control. Any difference between the proceeds transferred or received and the carrying amounts of the net assets is recognized in equity in the transferring and receiving entities’ separate financial statements and eliminated in consolidation. The change in accounting principle is applied retroactively for all periods presented.

 

Fiscal year end

 

The Company has selected December 31 as its fiscal year end.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported therein. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be based upon amounts that differ from these estimates.

 

Cash Equivalents

 

The Company considers all highly liquid investments with maturities of 90 days or less from the date of purchase to be cash equivalents.

 

COVID-19

 

The Company began seeing the impact of the COVID-19 pandemic on its business in early March 2020. The direct financial impact of the pandemic has primarily shown in significantly reduced production from the on-premises channel and higher labor and safety-related costs at the Company’s manufacturing facility. In addition to these direct financial impacts, COVID-19 related safety measures resulted in a reduction of manufacturing productivity. The Company will continue to assess and manage this situation and will provide a further update in each quarterly earnings release, to the extent that the effects of the COVID-19 pandemic are then known more clearly.

 

Revenue Recognition and Related Allowances

 

The Company recognizes revenue when obligations under the terms of a contract with its customer are satisfied; generally, this occurs with the transfer of control of its products. Revenue is measured as the amount of consideration expected to be received in exchange for transferring products. If the conditions for revenue recognition are not met, the Company defers the revenue and related cost of sales until all conditions are met. As of September 30, 2022 and December 31, 2021, the Company has deferred $1,235,438 and $1,104,923, respectively, in revenue, and $699,853 and $880,494 in cost of sales, respectively, related to customer orders in progress. These amounts are recorded as billings in excess of revenues and earnings in excess of billings in the accompanying balance sheets.

 

Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are stated at the amount that management expects to collect from outstanding balances. Bad debts and allowances are provided based on historical experience and management’s evaluation of outstanding accounts receivable. Management evaluates past due or delinquency of accounts receivable based on the open invoices aged on due date basis. The allowance for doubtful accounts at September 30, 2022 and December 31, 2021 is $0.

 

Inventories

 

Inventories consist of raw materials, work in process and finished goods. Raw materials, which principally consist of raw stainless steel, raw stainless tubing, motors, pumps, and fittings, are stated at the lower of cost, determined on the first-in, first-out basis, or net realizable value. During the year ended December 31, 2021, the Company wrote off $39,434 in obsolete inventory to the statement of operations. As of September 30, 2022 and December 31, 2021, the Company has inventory of $186,836 and $147,859, respectively.

9

 

 

Goodwill

 

The excess of the cost over the fair value of net assets of acquired in the Merger is recorded as goodwill. Goodwill is not subject to amortization, but is reviewed for impairment annually, or more frequently whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. An impairment charge would be recorded to the extent the carrying value of goodwill exceeds its estimated fair value. The testing of goodwill under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.

 

Capitalized Distribution Fees

 

The Company records its intangible assets at cost in accordance with ASC 350, Intangibles – Goodwill and Other. The Company reviews the intangible assets for impairment on an annual basis or if events or changes in circumstances indicate it is more likely than not that they are impaired. These events could include a significant change in the business climate, legal factors, a decline in operating performance, competition, sale, or disposition of a significant portion of the business, or other factors. If the review indicates the impairment, an impairment loss would be recorded for the difference of the value recorded and the new value. For the periods ended September 30, 2022 and December 31, 2021, there were no impairment losses recognized for intangible assets. The Company amortizes the capitalized distribution fees over a term of five years in connection with the distribution agreement.

 

Warranty

 

The Company is a manufacturer of products which are shipped to our customers directly from the Company. For products that are made from raw materials, the Company offers a 6-year limited warranty. The parts provided by outside vendors as finished goods that are added to a system produced by the Company as components, have a manufacturers’ warranty that is passed on to the end user of the complete system. To date, BrewBilt has spent less than $5,000 over the past 5 years for repairs (under warranty) on products they have built, with most of the costs going to cover travel and lodging expenses. As of September 30, 2022 and December 31, 2021, the Company has recorded a liability of $5,000 and $5,000, respectively, for warranties, which is included in accrued liabilities in the accompanying balance sheet.

 

Accounts Payable and Accrued Expenses

 

Accounts payable and accrued expenses are carried at amortized cost and represent liabilities for goods and services provided to the Company prior to the end of the fiscal year that are unpaid and arise when the Company becomes obliged to make future payments in respect of the purchase of these goods and services.

 

Fair Value of Financial Instruments

 

Fair value is defined as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk including our own credit risk.

 

In addition to defining fair value, the standard expands the disclosure requirements around fair value and establishes a fair value hierarchy for valuation inputs is expanded. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of the three levels, and which is determined by the lowest level input that is significant to the fair value measurement in its entirety.

 

These levels are:

 

Level 1 - inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.

 

10

 

Level 2 - inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 - inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques that include option pricing models, discounted cash flow models, and similar techniques.

 

Financial assets and liabilities measured at fair value on a recurring basis:

 

   Input  September 30, 2022   December 31, 2021 
   Level  Fair Value   Fair Value 
Derivative Liability  3  $616,318   $882,706 
Total Financial Liabilities     $616,318   $882,706 

 

In management’s opinion, the fair value of convertible notes payable and advances payable is approximate to carrying value as the interest rates and other features of these instruments approximate those obtainable for similar instruments in the current market. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest, exchange or credit risks arising from these financial instruments. As of September 30, 2022 and December 31, 2021, the balances reported for cash, accounts receivable, prepaid expenses, accounts payable, and accrued liabilities, approximate the fair value because of their short maturities.

 

Debt issuance costs and debt discounts

 

Debt issuance costs and debt discounts are being amortized over the lives of the related financings on a basis that approximates the effective interest method. Costs and discounts are presented as a reduction of the related debt in the accompanying consolidated balance sheets.

 

Income Taxes

 

The Company records deferred taxes in accordance with FASB ASC No. 740, Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and loss carryforwards and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rules on deferred tax assets and liabilities is recognized in operations in the year of change. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

 

As of the date of this filing, the Company is not current in filing their tax returns. The last return filed by the Company was December 31, 2019, and the Company has not accrued any potential penalties or interest from that period forward. The Company will need to file returns for the year ending December 31, 2021 and 2020, which is still open for examination.

 

Basic and Diluted Loss Per Share

 

In accordance with ASC Topic 280 – “Earnings Per Share”, the basic loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period after giving retroactive effect to the reverse stock split affected on April 28, 2022 (see Note 17). Diluted loss per common share is computed similar to basic loss per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.

 

11

 

Recent Accounting Pronouncements

 

Although there were new accounting pronouncements issued or proposed by the FASB during the nine months ending September 30, 2022 and through the date of filing of this report, the Company does not believe any of these accounting pronouncements has had or will have a material impact on its financial position or results of operations.

 

NOTE 2 – GOING CONCERN

 

The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As of September 30, 2022, the Company has a shareholders’ deficit of $14,640,699 since its inception, working capital deficit of $2,473,922, negative cash flows from operations, and has limited business operations, which raises substantial doubt about the Company’s ability to continue as going concern. The ability of the Company to meet its commitments as they become payable is dependent on the ability of the Company to obtain necessary financing or achieving a profitable level of operations. There is no assurance the Company will be successful in achieving these goals.

 

The Company does not have sufficient cash to fund its desired production for the next 12 months. The Company has arranged financing and intends to utilize the cash received to cover ongoing operational expenses. The Company plans to seek additional financing if necessary, in private or public equity offering(s) to secure future funding for operations. There can be no assurance the Company will be successful in raising additional funding. If the Company is not able to secure additional funding, the implementation of the Company’s business plan will be impaired. There can be no assurance that such additional financing will be available to the Company on acceptable terms or at all.

 

NOTE 3 - PREPAID EXPENSES

 

Prepaid fees represent amounts paid in advance for future contractual benefits to be received. Contracting expenses paid in advance are recorded as a prepaid asset and then amortized to the statements of operations when services are rendered, or over the life of the contract using the straight-line method.

 

As of September 30, 2022 and December 31, 2021, prepaid expenses consisted of the following:

 

 

   September 30,   December 31, 
   2022   2021 
Prepaid advertising expenses  $985,150   $ 
Prepaid insurance expenses   20,599    8,217 
Prepaid consulting expenses       40,000 
Prepaid Expense  $1,005,749   $48,217 

 

On September 15, 2021, Bennett Buchanan was appointed to serve as a director of BrewBilt Manufacturing, Inc. In connection with Mr. Buchanan’s appointment, the Company agreed to repurchase 10,000 shares of Series A Convertible Preferred Stock from Mr. Buchanan issued to him under his Consulting Agreement dated January 1, 2021, for an aggregate purchase price of $100,000, payable in five installments of $20,000 each over the six month period following his appointment as a director. During the year ended December 31, 2021, the company recorded payments of $40,000 in connection with this agreement. It recognized $80,000 in consulting fees in 2021 and $20,000 was recognized in the first quarter of 2022.

 

On June 10, 2022, the Company agreed to modify the IP Purchase and License Agreement with Maguire and Associates, LLC, dated October 15, 2020. Pursuant to the Amendment, the Company agreed to issue an additional 200,000 Preferred Series A shares, valued at $2,000,000, and in return, Maguire and Associates agrees to take full responsibility for outstanding, unpaid advertising fees and all future advertising costs in the USA for the next 24 months. The Company recorded $1,000,000 in prepaid expenses and recorded $1,000,000 in non-current assets on the balance sheet. During the nine months ended September 30, 2022, Maguire & Associates paid $14,850 in advertising expenses which was reclassified to the statement of operations.

 

12

 

NOTE 4 – PROPERTY AND EQUIPMENT

 

Property and equipment consisted of the following at September 30, 2022 and December 31, 2021:

 

 

   September 30,   December 31, 
   2022   2021 
Computer Equipment  $23,876   $23,876 
Leasehold Improvements   131,890    131,890 
Machinery   352,187    352,187 
Software   23,183    23,183 
Vehicles   6,717    6,717 
Property, Plant and Equipment, Gross   537,853    537,853 
Less accumulated amortization   (21,657)   (14,198)
Less accumulated depreciation   (307,888)   (274,447)
Property, Plant and Equipment, Net  $208,308   $249,208 

 

During the year ended December 31, 2021, the company recorded fixed assets additions of $276,035 and fixed asset proceeds of $90,746. Depreciation and amortization expenses of $40,900 and $30,691 were recorded to the statement of operations for the nine months ended September 30, 2022 and 2021, respectively.

 

NOTE 5 – LEASES

 

The Company adopted the new lease guidance effective January 1, 2019 using the modified retrospective transition approach, applying the new standard to all of its leases existing at the date of initial application which is the effective date of adoption. Consequently, financial information will not be updated, and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. We elected the package of practical expedients which permits us to not reassess (1) whether any expired or existing contracts are or contain leases, (2) the lease classification for any expired or existing leases, and (3) any initial direct costs for any existing leases as of the effective date. We did not elect the hindsight practical expedient which permits entities to use hindsight in determining the lease term and assessing impairment. The adoption of the lease standard did not change our previously reported consolidated statements of operations and did not result in a cumulative catch-up adjustment to opening equity.

 

The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. In calculating the present value of the lease payments, the Company elected to utilize its incremental borrowing rate based on the remaining lease terms as of the January 1, 2019 adoption date.

 

Operating Leases

 

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred, if any. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Our lease has a remaining lease term of 3.25 years.

 

The Company has elected the practical expedient to combine lease and non-lease components as a single component. The lease expense is recognized over the expected term on a straight-line basis. Operating leases are recognized on the balance sheet as right-of-use assets, current operating lease liabilities and non-current operating lease liabilities.

 

The new standard also provides practical expedients and certain exemptions for an entity’s ongoing accounting. We have elected the short-term lease recognition exemption for all leases that qualify. This means, for those leases where the initial lease term is one year or less or for which the ROU asset at inception is deemed immaterial, we will not recognize ROU assets or lease liabilities. Those leases are expensed on a straight-line basis over the term of the lease.

 

On January 1, 2020, the Company entered into a standard office lease for approximately 8,000 square feet of space, located in the Wolf Creek Industrial Building at 110 Spring Hill Dr. #10 Grass Valley, CA 95945. The lease has a term of five years, from January 1, 2020 through December 31, 2025, with a monthly rent of $4,861.

 

13

 

As of September 30, 2022 and December 31, 2021, ROU assets and lease liabilities related to our operating lease is as follows:

 

Schedule of Right of use of assets and lease liabilities 

   September 30,   December 31, 
   2022   2021 
Right-of-use assets  $169,805   $203,991 
Current operating lease liabilities   48,350    45,970 
Non-current operating lease liabilities   121,455    158,021 

 

The following is a schedule, by years, of future minimum lease payments required under the operating lease:

 

 

Years Ending    
December 31,  Operating Lease 
2022  $14,584 
2023   58,334 
2024   58,334 
2025   58,335 
Total   189,587 
Less imputed interest   19,782 
Total liability  $169,805 

 

NOTE 6 – INTANGIBLES

 

On August 20, 2021, the company entered into an Exclusive Distribution Agreement with South Pacific Traders Oy. Pursuant to the agreement, the company will issue 50,000 Series A Convertible Preferred stock at $10 per share. South Pacific Traders will market BrewBilt Manufacturing equipment to the European Community and United Kingdom. Management determined that the 50,000 Series A Convertible Preferred to be issued as consideration for the exclusive distribution agreement is a finite-lived intangible asset and will be amortized over the five year term of the agreement.

 

On January 17, 2022, the company issued 50,000 shares, and $500,000 was reclassified from Convertible Stock Payable to Series A Convertible Preferred Stock. During the nine month period ending September 30, 2022, the company amortized $75,000 of the capitalized distribution fees to the statement of operations.

 

NOTE 7 – ACCRUED LIABILITIES

 

As of September 30, 2022 and December 31, 2021, accrued liabilities were comprised of the following:

 

 

   September 30,   December 31, 
   2022   2021 
Accrued liabilities          
Accrued wages  $31,294   $31,294 
Credit card   7,200    6,045 
Payroll taxes   101,915     
Sales tax payable   89,820    76,751 
Warranty   5,000    5,000 
Total accrued expenses  $235,229   $119,090 

14

 

NOTE 8 – BILLINGS IN EXCESS OF REVENUE AND EARNINGS IN EXCESS OF BILLINGS

 

Billings in excess of revenue is related to contracted amounts that have been invoiced to customers for which remaining performance obligations must be completed before the Company can recognize the revenue. Earnings in excess of billings is related to the cost of sales associated with the customer jobs that are incomplete.

 

Changes in unearned revenue for the periods ended September 30, 2022 and December 31, 2021 were as follows:

 

 

   September 30,   December 31, 
   2022   2021 
Unearned revenue, beginning of the period  $1,104,923   $71,280 
Billings in excess of revenue during the period   1,195,357    1,722,715 
Recognition of unearned revenue in prior periods   (1,064,842)   (689,072)
Unearned revenue, end of the period  $1,235,438   $1,104,923 

 

As of September 30, 2022 and December 31, 2021, the Company has recorded $699,853 and $880,494, respectively in earnings in excess of billings for the cost of sales related to customer orders in progress.

 

NOTE 9 – CONVERTIBLE NOTES PAYABLE

 

As of September 30, 2022 and December 31, 2021, notes payable were comprised of the following:

 

 

   Original   Original  Due  Interest  Conversion  September 30,   December 31, 
   Note Amount   Note Date  Date  Rate  Rate  2022   2021 
1800 Diagonal Lending #1  $53,750   4/29/2022  4/29/2023  10%  Variable  $53,750   $ 
1800 Diagonal Lending #2   54,250   7/26/2022  7/26/2023  10%  Variable   54,250     
CBP #3   30,000   5/1/2020  5/1/2021  15%  Variable       9,576 
CBP #4   30,000   7/23/2020  7/23/2021  15%  Variable       30,000 
Emerging Corp Cap #2   110,000   10/31/2018  10/31/2019  24%  Variable   110,000    110,000 
GPL Ventures #3   240,000   5/6/2021  5/6/2022  10%  0.001       240,000 
Mammoth Corp #1   33,000   11/19/2020  8/19/2021  18%  Variable   33,000    33,000 
Mammoth Corp #2   60,000   12/30/2021  12/30/2022  0%  Variable   60,000    60,000 
Mammoth Corp #3   26,800   03/21/22  12/21/22  0%  Variable   26,800     
Mast Hill Fund #1   550,000   10/6/2021  10/6/2022  12%  0.0015   437,652    550,000 
Mast Hill Fund #2   65,000   8/8/2022  8/8/2023  12%  0.0025   65,000     
Optempus #1   25,000   7/2/2020  7/2/2021  22%  Variable       25,000 
Optempus #2   25,000   7/7/2020  7/2/2021  22%  Variable       25,000 
Optempus #3   15,000   11/24/2020  11/24/2021  10%  Variable       15,000 
Optempus #4   40,000   12/29/2020  12/29/2021  10%  Variable       40,000 
Power Up Lending #23   43,750   8/11/2021  8/11/2022  10%  Variable       43,750 
Power Up Lending #24   48,750   9/14/2021  9/14/2022  10%  Variable       48,750 
Power Up Lending #25   43,750   10/8/2021  10/8/2022  10%  Variable       43,750 
Tri-Bridge #3   25,000   1/14/2021  7/14/2021  10%  Variable       25,000 
Tri-Bridge #4   25,000   2/24/2021  8/24/2021  10%  Variable       25,000 
Tri-Bridge #5   240,000   5/6/2021  5/6/2022  10%  0.001   211,500    240,000 
                    $1,051,952   $1,563,826 
Debt discount                    (71,457)   (527,933)
Financing costs/Original issue discount         (21,675)   (125,831)
Notes payable, net of discount       $958,820   $910,062 

15

 

During the nine months ending September 30, 2022, the Company received proceeds from new convertible notes of $309,320. The Company recorded $66,488 in penalties, cash payments of $153,611 and conversions of $614,974 of convertible note principal. The Company settled $105,000 in note payable principal with the issuance of 10,500 Convertible Series A shares, valued at $105,000. Convertible note principal in the amount of $39,576 was forgiven by a note holder, and the Company recorded a gain on forgiveness of debt of $39,576 to the statement of operations. The Company recorded loan fees on new convertible notes of $25,480, which increased the debt discounts recorded on the convertible notes during the nine months ending September 30, 2022. Some of the Company’s convertible notes have a conversion rate that is variable, and therefore, the Company has accounted for their conversion features as derivative instruments (see Note 11). The Company also recorded amortization of $836,459 on their convertible note debt discounts and loan fees. As of September 30, 2022, the convertible notes payable are convertible into 1,705,001,719 shares of the Company’s common stock.

 

During the nine months ended September 30, 2022, the Company recorded interest expense of $116,312, payments of $4,021, conversions of $96,160 and conversion fees of $14,000 on its convertible notes payable. The Company recorded a gain of $22,029 for the settlement of notes payable. Convertible note interest in the amount of $12,180 was forgiven by a note holder, and the Company recorded a gain on forgiveness of debt of $12,180 to the statement of operations. As of September 30, 2022, the accrued interest balance was $135,045.

 

As of September 30, 2022, we have not attained profitable operations and are dependent upon obtaining financing to pursue any extensive acquisitions and activities.

 

NOTE 10 – PROMISSORY NOTES PAYABLE

 

On January 5, 2021, the Company received funding pursuant to a promissory note in the amount of $50,000, of which, $39,000 was received in cash and $11,000 was recorded as transaction fees. The note bears interest of 12% (increases to 16% per annum upon an event of default) and matures on January 5, 2022. As of September 30, 2022, the company has amortized $11,000 of the financing costs to the statement of operations. As of September 30, 2022, the note has a principal balance of $50,000 and accrued interest of $11,874.

 

On July 15, 2021, the Company received funding pursuant to a promissory note in the amount of $75,000, of which $62,500 was received in cash and $12,500 was recorded as transaction fees. The note bears interest of 12% (increases to 16% per annum upon an event of default) and matures on July 15, 2022. As of September 30, 2022, the company has amortized $12,500 of the financing costs to the statement of operations. As of September 30, 2022, the note has a principal balance of $75,000 and accrued interest of $11,532.

 

On September 14, 2021, the Company received funding pursuant to a promissory note in the amount of $100,000, of which, $82,500 was received in cash and $17,500 was recorded as transaction fees. The note bears interest of 12% (increases to 16% per annum upon an event of default) and matures on September 14, 2022. As of September 30, 2022, the company has amortized $17,500 of the financing costs to the statement of operations. As of September 30, 2022, the note has a principal balance of $100,000 and accrued interest of $12,701.

 

On June 9, 2022, the Company received funding pursuant to a promissory note in the amount of $200,000, of which, $170,000 was received in cash and $30,000 was recorded as transaction fees. The note bears interest of 10% (increases to 18% per annum upon an event of default), which is guaranteed and earned in full as of the issue date. The note matures on June 9, 2023. As of September 30, 2022, the company has amortized $9,288 of the financing costs to the statement of operations. As of September 30, 2022, the note has a principal balance of $200,000 and accrued interest of $20,000.

16

 

NOTE 11 – DERIVATIVE LIABIITIES

 

During the nine months ended September 30, 2022, the Company valued the embedded conversion feature of the convertible notes and warrants. The Company uses the Black-Scholes option pricing model to estimate fair value for those instruments convertible into common shares at inception, at conversion or extinguishment date, and at each reporting date.

 

The following table represents the Company’s derivative liability activity for the embedded conversion features for the nine months ended September 30, 2022:

 

 

   Notes   Warrants   Total 
Balance, beginning of period  $736,994   $145,712   $882,706 
Initial recognition of derivative liability   431,240    130,000    561,240 
Derivative settlements   (1,135,481)   (148,314)   (1,283,795)
Loss (gain) on derivative liability valuation   562,151    (105,984)   456,167 
Balance, end of period  $594,904   $21,414   $616,318 

 

Convertible Notes

 

The fair value at the commitment date for the convertible notes and the revaluation dates for the Company’s derivative liabilities were based upon the following management assumptions as of September 30, 2022:

 

   Valuation date
Expected dividends  0%
Expected volatility  204.88% - 308.80%
Expected term  .01 - 1 year
Risk free interest  1.36% - 4%

 

Warrants

 

We account for common stock purchase warrants as derivative liabilities and debt issuance costs on the balance sheet at fair value, and changes in fair value during the periods presented in the statement of operations, which is revalued at each balance sheet date subsequent to the initial issuance of the warrant.

 

The fair value at the commitment date for the warrants and the revaluation dates for the Company’s derivative liabilities were based upon the following management assumptions as of September 30, 2022:

 

   Valuation date
Expected dividends  0%
Expected volatility  1,448.16% - 2,499.52%
Expected term  2.725 years
Risk free interest  2.91% - 4.25%

 

NOTE 12 – WARRANTS

 

The following table summarizes information with respect to the outstanding warrants to purchase common stock of the Company, all of which were exercisable as of September 30, 2022:

 

Exercise Price   Number Outstanding   Expiration Date
$6.0000    18,000   June 18, 2025
$0.6000    83,333   January 5, 2026
$0.6000    83,333   January 5, 2026
$0.6000    125,000   July 15, 2026
$0.6000    125,000   July 15, 2026
$0.6000    166,667   September 14, 2026
$0.6000    166,667   September 14, 2026
$0.0025    26,000,000   August 8, 2027
      26,768,000    

17

 

A summary of warrant activity for the nine months ended September 30, 2022 is as follows:

 

           Weighted-Average     
       Weighted-Average   Remaining   Aggregate 
Warrants  Shares   Exercise Price   Contractual Term   Intrinsic Value 
Outstanding at December 31, 2021   809,686   $1.0100    4.43   $ 
Granted   26,000,000               
Exercised   -37,666               
Forfeited or expired   -4,020               
Outstanding at September 30, 2022   26,768,000   $0.0233    4.83   $ 
Exercisable at September 30, 2022   26,768,000   $0.0233    4.83   $ 

 

The aggregate intrinsic value in the preceding tables represents the total pre-tax intrinsic value, based on options with an exercise price that is higher than the Company’s market stock price of $0.0008 on September 30, 2022.

 

NOTE 13 – RELATED PARTY TRANSACTIONS

 

Consulting Agreements

 

On June 19, 2019, the Company entered into a Consulting Agreement with Mr. Samuel Berry. The agreement is for a term of one year and is renewable upon mutual consent. Mr. Berry will receive an annual salary of $50,000, payable in quarterly installments at $12,500 per quarter. As of December 31, 2021, Mr. Berry had an unpaid balance of $118,167. During the nine months ended September 30, 2022, the Company accrued $37,500 in fees and made $15,000 in payments in connection to his agreement. As of September 30, 2022, the Company owed Mr. Berry $140,667 in fees.

 

On January 1, 2021, the Company entered into a Consulting Agreement with Bennett Buchanan to assist with marketing, advertising, customer relations, and licensing and compliance regulatory requirements. The term of the Agreement is for two years and may be terminated or extended upon mutual agreement of both parties pursuant with a thirty-day written notice. The Company will pay the Consultant a monthly fee of $3,000 and $100,000 in Series A Stock during the term of the agreement.

 

On November 1, 2021, the parties agreed to terminate the agreement dated January 1, 2021 and entered into a new Employee Agreement. The term of the Agreement is for two years and may be terminated or extended upon mutual agreement of both parties pursuant with a thirty-day written notice. The Company agreed to pay the Consultant a monthly fee of $3,000 and $100,000 in Convertible Preferred Series A stock.

 

Director Agreements

 

On January 1, 2022, the Company entered into a Directors Agreement with Jef Lewis for a term of one year. In exchange for serving in this capacity, the Company will issue 5,000 shares of Convertible Preferred Series A stock at a price of $10 per share. The shares are restricted and cannot be sold or otherwise transferred by the undersigned except as provided by law, and in no event, prior to the maturity date of six (6) months.

 

18

 

On January 1, 2022, the Company entered into a Directors Agreement with Sam Berry for a term of one year. In exchange for serving in this capacity, the Company will issue 5,000 shares of Convertible Preferred Series A stock at a price of $10 per share. The shares are restricted and cannot be sold or otherwise transferred by the undersigned except as provided by law, and in no event, prior to the maturity date of six (6) months.

 

On January 1, 2022, the Company entered into a Directors Agreement with Bennett Buchanan for a term of one year. In exchange for serving in this capacity, the Company will issue 5,000 shares of Convertible Preferred Series A stock at a price of $10 per share. The shares are restricted and cannot be sold or otherwise transferred by the undersigned except as provided by law, and in no event, prior to the maturity date of six (6) months.

 

NOTE 14 – LONG TERM DEBT

 

As of September 30, 2022 and December 31, 2021, long term debt was comprised of the following:

 

   September 30,   December 31, 
   2022   2021 
Long term debt          
Equipment loan   27,001    41,134 
Line of credit   117,199    111,256 
Total long term debt  $144,200   $152,390 

 

Equipment Loan

 

In August 2021, the Company returned $96,357 in equipment to the lender to settle debt of $74,480, and a loss on disposal of assets of $16,267 was recorded to the statement of operations.

 

NOTE 15 – CONVERTIBLE PREFERRED STOCK

 

Series A Convertible Preferred Stock

 

On July 1, 2019, the Company filed a Certificate of Amendment to increase the number of authorized Series A Convertible Preferred Stock to 30,000,000, with a par value of $0.001. Each share of Convertible Preferred Series A Stock shall have a value of $10 per share and will convert into common stock at the closing price of the common stock on the date of conversion. The Series A stock shall have no voting rights on corporate matters, unless and until the Series A shares are converted into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action.

 

Pursuant to the Merger Agreement dated November 22, 2019, the Company issued $5,000,000 worth of Series A Convertible Preferred stock to Mr. Lewis. The number of Series A Convertible Preferred shares to be issued is 500,000 shares at a price of $10 per share and convertible pursuant the conversion rights as specified in the Articles of Incorporation and Certificate of Designation for the Company. As of December 31, 2019, the shares had not been issued, and the Company recorded a liability for unissued shares in the amount of $500, goodwill of $2,289,884 and $2,289,334 to additional paid in capital. On March 1, 2020, 500,000 shares of Series A Convertible Preferred shares were issued pursuant to the Merger Agreement.

 

On April 6, 2020, the Company executed an addendum to the Distribution & Licensing Agreement dated November 19, 2019, with Bgreen Partners, Inc. The Company issued 400,000 Series A Convertible Preferred shares at a price of $10 per share which are convertible pursuant the conversion rights as specified in the Articles of Incorporation and certificate of designation for the Company.

 

19

 

On October 15, 2020, the Company entered into an IP Purchase and License Agreement with Maguire & Associates, LLC in the amount of $5,000,000. The Company issued 500,000 Series A Convertible Preferred shares at a price of $10 per share which are convertible pursuant the conversion rights as specified in the Articles of Incorporation and certificate of designation for the Company.

 

On November 20, 2020, Mr. Lewis converted 233,333 common shares at a price of $0.54 per share into 54,000 Series A Convertible Preferred shares at a price of $10 per share. The conversion resulted in a loss of $414,000 which was recorded to the statement of operations.

 

During the year ended December 31, 2020, 734,000 shares of Series A Convertible Preferred stock were converted to 8,055,557 common shares in accordance with the conversion terms. The issuances resulted in a loss on conversion of $1,572,272 which was recorded to the statement of operations.

 

On January 1, 2021, the Company issued 10,000 shares of Series A Convertible Preferred stock at $10 per share to Bennett Buchanan, pursuant to his Consulting Agreement dated January 1, 2021.

 

On April 13, 2021, the Company issued 10,000 shares of Series A Convertible Preferred stock to key employee Corbin Boyle at $10 per share.

 

On April 13, 2021, the Company issued 10,000 shares of Series A Convertible Preferred stock to key employee Jesse Prim at $10 per share.

 

On May 14, 2021, the Company issued 14,497 shares of Series A Convertible Preferred stock at $10 per share, to settle liabilities of $144,970.

 

On September 15, 2021, the Company repurchased 10,000 shares of Series A Convertible Preferred stock at $10 per share from Bennett Buchanan, pursuant to his Director Agreement. The shares were purchased for $100,000, which is payable in five installments of $20,000 each over the six-month period following his appointment as a director.

 

On December 1, 2021, the Company issued 10,000 shares of Series A Convertible Preferred stock at $10 per share to Bennett Buchanan, pursuant to his Consulting Agreement dated November 1, 2021.

 

On December 8, 2021, the Company issued 500,000 shares of Series A Convertible Preferred stock at $10 per share to Jef Lewis, pursuant to his Employment Agreement dated October 1, 2021.

 

On December 27, 2021, the Company issued 100,000 of Series A Convertible Preferred shares to Mr. Berry for his four years of service as a Director for the company.

 

During the year ended December 31, 2021, 434,780 shares of Series A Convertible Preferred stock were converted to 8,917,068 common shares in accordance with the conversion terms. The issuances resulted in a loss on conversion of $2,200,126, which was recorded to the statement of operations.

 

On March 2, 2022, the Company issued 5,000 shares of Series A Convertible Preferred stock to key employee Andrew Salo at $10 per share.

 

On March 4, 2022, the Company issued 2,500 shares of Series A Convertible Preferred stock for advertising services provided by Jef Freeman at $10 per share.

 

On April 1, 2022, the Company agreed to issue 10,500 shares of Series A Convertible Preferred stock to settle $105,000 of Convertible Notes owned by Maguire and Associates, LLC. The shares were valued at $105,000.

 

On June 9, 2022, Jef Lewis converted 200,000 shares of Series A Convertible Preferred stock, valued at $2,000,000 in to 200,000,000 common shares. The issuance resulted in a gain on conversion of $40,000, which was recorded to the statement of operations during the nine months ended September 30, 2022.

 

On June 10, 2022, the Company agreed to modify the IP Purchase and License Agreement with Maguire and Associates, LLC, dated October 15, 2020. Pursuant to the Amendment, the Company agreed to issue an additional 200,000 shares of Series A Convertible Preferred stock, valued at $2,000,000, and in return, Maguire and Associates agrees to take full responsibility for all outstanding, unpaid advertising costs and all future advertising costs in the USA for the next 24 months. The Company recorded $1,000,000 in prepaid expenses and recorded $1,000,000 in non-current assets on the balance sheet.

20

 

During the nine months ended September 30, 2022, 33,665 shares of Series A Convertible Preferred stock were converted to 21,365,471 common shares in accordance with the conversion terms. The issuances resulted in a loss on conversion of $185,572, which was recorded to the statement of operations.

 

The Series A Convertible Preferred Stock has been classified outside of permanent equity and liabilities since it embodies a conditional obligation that the Company may settle by issuing a variable number of equity shares and the monetary value of the obligation is based on a fixed monetary amount known at inception. Each share of the Series A Convertible Preferred Stock has a fixed value of $10 per share, has no voting rights, and is convertible into common stock at closing market price on the date of conversion. The Company has recorded $13,640,520, which represents 1,364,052 Series A Convertible Preferred Stock at $10 per share, issued and outstanding as of September 30, 2022, outside of permanent equity and liabilities.

 

Preferred Stock Payable

 

On August 20, 2021, the company agreed to issue 50,000 Convertible Preferred Series A shares at $10 per share to South Pacific Traders Oy pursuant to an exclusive distribution agreement. The shares were issued on January 17, 2022 and $500,000 was reclassified to Series A Convertible Preferred Stock.

 

On January 1, 2022, the company agreed to issue 5,000 Convertible Series A shares at $10 per share to Jef Lewis, Sam Berry, and Bennett Buchanan, pursuant to Directors Agreements.

 

On August 1, 2022, the company agreed to issue 1,600 Convertible Series A shares at $10 per share to Christopher Bullock, pursuant to a Consulting Agreement.

 

NOTE 16 – PREFERRED STOCK

 

On March 28, 2017, the Company filed an amendment to its articles of incorporation designating 20,000 shares of its authorized preferred stock, par value $0.001 as Series B Voting Preferred Stock. The Series B Voting Preferred Stock shall have the right to vote the shares on any matter requiring shareholder approval on the basis of 4 times the votes of all the issued and outstanding shares of common stock, as well as any issued and outstanding preferred stock.

 

On November 22, 2019, President Jef Lewis was issued 1,000 Preferred Series B Control Shares, pursuant to his employee agreement dated November 22, 2019.

 

As of September 30, 2022, 1,000 Series B Preferred shares were authorized, of which 1,000 Series B shares were issued and outstanding.

 

NOTE 17 – COMMON STOCK

 

On April 22, 2019, the Company approved the authorization of a 1 for 3,000 reverse stock split of the Company’s outstanding shares of common stock. The Company’s financial statements have been retroactively adjusted for this stock split for all periods presented.

 

During the year ended December 31, 2019, the holder of a convertible note converted $1,148 of accrued interest and $500 in conversion fees into 1,333 shares of common stock. The common stock was valued at $5,077 based on the market price of the Company’s stock on the date of conversion.

 

On March 17, 2020, the Company’s former President cancelled 26,694 shares of common stock issued to settle debt of $25,342 and $25,000 in stock based compensation pursuant to an employee agreement. The cancellation resulted in a liability of unissued shares of $25,000 and an increase in related party liabilities of $25,342. On December 31, 2020, Mr. Rushford agreed to forgive the debt and $50,342 was recorded to additional paid in capital.

 

21

 

On March 25, 2020, the Company filed a Certificate of Amendment to increase the number of authorized common shares from 5,000,000,000 to 10,000,000,000 with a par value of $0.001.

 

On November 20, 2020, Mr. Lewis converted 233,333 common shares at a price of $0.54 per share into 54,000 Series A Convertible Preferred shares at a price of $10 per share. The conversion resulted in a loss of $414,000 which was recorded to the statement of operations.

 

On December 4, 2020, the Company filed a Certificate of Amendment to increase the number of authorized common shares from 10,000,000,000 to 20,000,000,000 with a par value of $0.001.

 

During the year ended December 31, 2020, 734,000 shares of Series A Convertible Preferred stock were converted to 8,055,557 common shares in accordance with the conversion terms. The issuances resulted in a loss on conversion of $1,572,272 which was recorded to the statement of operations.

 

During the year ended December 31, 2020, the holders of a convertible notes converted $1,388,809 of principal, $351,376 of accrued interest and $39,275 in conversion fees into 3,412,726 shares of common stock. The common stock was valued at $8,141,166 based on the market price of the Company’s stock on the date of conversion.

 

On June 10, 2021, the Company filed a Certificate of Amendment to increase the number of authorized common shares from 20,000,000,000 to 25,000,000,000 with a par value of $0.001.

 

During the year ended December 31, 2021, warrant holders exercised the warrants and the Company issued 1,286,690 shares of common stock through a cashless exercise of the warrants in accordance with the conversion terms.

 

During the year ended December 31, 2021, 434,780 shares of Series A Convertible Preferred stock were converted to 8,917,068 common shares in accordance with the conversion terms. The issuances resulted in a loss on conversion of $2,200,126, which was recorded to the statement of operations.

 

During the year ended December 31, 2021, the holders of a convertible notes converted $984,042 of principal, $78,686 of accrued interest and $7,750 in conversion fees into 4,387,505 shares of common stock. The common stock was valued at $3,768,693 based on the market price of the Company’s stock on the date of conversion.

 

During the year ended December 31, 2021, the holder of a promissory notes converted $108,000 of principal, $12,960 of accrued interest, $15,000 in penalties, and $750 in conversion fees into 660,435 shares of common stock. The common stock was valued at $594,391 based on the market price of the Company’s stock on the date of conversion, and the company recorded a loss on conversion of $457,681 to the statement of operations.

 

On April 20, 2022, the Company approved the authorization of a one for three hundred reverse stock split of the Company’s outstanding shares of common stock. The reverse split was effective on April 28, 2022, and the financial statements have been retroactively adjusted to take this into account for all periods presented. The Company issued 8,062 common shares due to rounding in connection with the reverse stock split. In addition, the Company reduced the number of authorized shares from 25,000,000,000 to 83,333,333 shares with a par value of $0.001.

 

On April 26, 2022 the Company filed a Certificate of Amendment to increase the number of authorized common shares from 83,333,333 to 5,000,000,000 with a par value of $0.001.

 

On June 9, 2022, the Company issued 4,000,000 shares of common stock valued at $40,000, to Coventry Enterprises LLC pursuant to a note agreement.

 

On June 9, 2022, Jef Lewis converted 200,000 shares of Series A Convertible Preferred stock, valued at $2,000,000 in to 200,000,000 common shares. The issuance resulted in a gain on conversion of $40,000, which was recorded to the statement of operations during the nine months ended September 30, 2022.

 

On July 21, 2022 the Company filed a Certificate of Amendment to increase the number of authorized common shares from 5,000,000,000 to 15,000,000,000 with a par value of $0.001.

 

22

 

On August 22, 2022, the Company cancelled 60,000 shares of common stock pursuant to a Settlement Agreement.

 

During the nine months ended September 30, 2022, warrant holders exercised the warrants and the Company issued 43,516,026 shares of common stock through a cashless exercise of the warrants in accordance with the conversion terms.

 

During the nine months ended September 30, 2022, 33,665 shares of Series A Convertible Preferred stock were converted to 21,365,471 common shares in accordance with the conversion terms. The issuances resulted in a loss on conversion of $185,572, which was recorded to the statement of operations.

 

During the nine months ended September 30, 2022, the holders of a convertible notes converted $614,974 of principal, $96,160 of accrued interest and $14,000 in conversion fees into 340,111 shares of common stock. The common stock was valued at $1,777,986 based on the market price of the Company’s stock on the date of conversion, and a loss on conversion of $1,052,852 was recorded to the statement of operations.

 

As of September 30, 2022, 15,000,000,000 were authorized, of which 635,971,617 shares are issued and outstanding.

 

NOTE 18 – INCOME TAX

 

Deferred income taxes are determined using the liability method for the temporary differences between the financial reporting basis and income tax basis of the Company’s assets and liabilities. Deferred income taxes are measured based on the tax rates expected to be in effect when the temporary differences are included in the Company’s tax return. Deferred tax assets and liabilities are recognized based on anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases.

 

The deferred tax asset and the valuation allowance consist of the following at September 30, 2022:

 

 

   September 30, 
   2022 
Net operating loss  $1,551,145 
Statutory rate   21%
Expected tax recovery   325,740 
Change in valuation allowance   (325,740)
Income tax provision  $ 
      
Components of deferred tax asset:     
Non-capital tax loss carry-forwards   325,740 
Less: valuation allowance   (325,740)
Net deferred tax asset  $ 

 

As of the date of this filing, the Company is not current in filing their tax returns. The last return filed by the Company was December 31, 2019, and the Company has not accrued any potential penalties or interest from that period forward. The Company will need to file returns for the year ending December 31, 2021 and 2020, which is still open for examination.

 

NOTE 19 – COMMITMENTS AND CONTINGENCIES

 

Consulting Agreement

 

On August 1, 2022, the Company entered into a Consulting Agreement with Christopher Bullock as a sales representative in India. The term of the agreement is for two years and may be terminated or extended upon mutual agreement of both parties pursuant with a ninety-day written notice. Upon execution of the agreement, the Company agreed to issue $10,000 of Series A Convertible Preferred stock to the Consultant. The Consultant will receive a monthly fee of $3,000, to be paid Series A Convertible Preferred stock, and will receive a 2% commission on gross sales for all products sold in India. As of September 30, 2022, the shares have not been issuance and $16,000 has been recorded to Convertible preferred stock payable on the balance sheet.

 

23

 

Operating Lease

 

On January 1, 2020, the Company entered into a new office lease for space located in the Wolf Creek Industrial Building at 110 Spring Hill Dr. #10 Grass Valley, CA 95945. The lease has a term of 5 years, from January 1, 2020 through December 31, 2025, with a monthly rent of $4,861.

 

Service Agreement

 

On June 12, 2018, the Company entered into a preventative maintenance service agreement with Atlas Copco Compressions LLC. The agreement is for a period of 5 years, at a cost of $145.13 per month.

 

NOTE 20 – SUBSEQUENT EVENTS

 

Platform Account Contract

 

On October 1, 2022, the Company entered into a Platform Account Contract with SRAX, Inc, whereby the Company agreed to pay $30,000 for access to the SRAX platform for a period of 12-months from the effective date. The platform access fee is non-cancelable and will be deemed fully earned on the effective date of the Agreement. In addition, the Company agrees to a deliverable purchase fee for marketing advisory services in the amount of $270,000 which is due on the effective date. All fees will be paid in Convertible Preferred Series A stock.

 

Notes Payable

 

On October 3, 2022, the Company entered into a Convertible Note in the amount of $110,000. The note is unsecured, bears interest at 12% per annum, and matures on October 3, 2023. In connection with the note, the Company executed a Common Stock Purchase Warrant for 110,000,000 shares. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price of $0.001 per share and expire on October 3, 2027.

 

Subsequent Issuances

 

On October 6, 2022, a warrant holder exercised the warrants and the Company issued 30,227,710 shares of common stock through a cashless exercise of the warrants in accordance with the conversion terms.

 

On October 10, 2022, a warrant holder exercised the warrants and the Company issued 33,243,346 shares of common stock through a cashless exercise of the warrants in accordance with the conversion terms.

 

On October 21, 2022, a warrant holder exercised the warrants and the Company issued 27,180,426 shares of common stock through a cashless exercise of the warrants in accordance with the conversion terms.

 

On October 31, 2022, a warrant holder exercised the warrants and the Company issued 36,258,492 shares of common stock through a cashless exercise of the warrants in accordance with the conversion terms.

 

On November 4, 2022, the holder of a convertible note converted a total of $1,293 of interest into 25,861,490 shares of our common stock.

 

The Company has evaluated subsequent events pursuant to ASC Topic 855 and has determined that there are no additional subsequent events to disclose.

24

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

 

The following discussion and analysis summarizes the significant factors affecting our consolidated results of operations, financial condition, and liquidity position for the three and nine months ended September 30, 2022. This discussion and analysis should be read in conjunction with our audited financial statements and notes thereto included in our Annual Report on Form 10-K for our year-ended December 31, 2021 and the consolidated unaudited financial statements and related notes included elsewhere in this filing. The following discussion and analysis contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements.

 

FORWARD-LOOKING STATEMENTS

 

This quarterly report contains forward-looking statements relating to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “intends”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential”, or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors which may cause our or our industry’s actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements.

 

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these statements, which speak only as of the date that they were made. These cautionary statements should be considered with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results, later events, or circumstances or to reflect the occurrence of unanticipated events.

 

In this report unless otherwise specified, all dollar amounts are expressed in United States dollars and all references to “common shares” refer to the common shares of our capital stock.

 

The management’s discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

 

As used in this quarterly report, the terms “we”, “us”, “our”, and “our company” means BrewBilt Manufacturing, Inc., unless otherwise indicated.

 

RESULTS OF OPERATIONS

 

Results for the Three Months Ended September 30, 2022 Compared to the Three Months Ended September 30, 2021

 

Revenues:

 

The Company’s revenues were $118,219 for the three months ended September 30, 2022 compared to $575,128 for the three months ended September 30, 2021. The decrease is due to a large job that was completed during the three months ended September 30, 2021

 

Cost of Sales:

 

The Company’s cost of materials was $79,455 for the three months ended September 30, 2022, compared to $357,429 for the three months ended September 30, 2021. The decrease is due to fewer and smaller jobs completed in Q3 2022.

25

 

Operating Expenses:

 

Operating expenses consisted primarily of consulting fees, professional fees, salaries and wages, office expenses and fees associated with preparing reports and SEC filings relating to being a public company. Operating expenses for the three months ended September 30, 2022, and September 30, 2021, were $383,294 and $249,912, respectively. The increase is due to an increase in consulting fees and salaries and wages.

 

Other Income (Expense):

 

Other income (expense) for the three months ended September 30, 2022 and September 30, 2021 was $642,481 and $(1,486,665), respectively. Other income (expense) consisted of gains on debt forgiveness, gains or losses on derivative valuation, losses on conversion on preferred stock to common stock and interest expense. The gain or loss on derivative valuation is directly attributable to the change in fair value of the derivative liability. Interest expense is primarily attributable the initial interest expense associated with the valuation of derivative instruments at issuance and the accretion of the convertible debentures over their respective terms. The increase in other income primarily resulted from the fluctuation of the Company’s stock price which impacted the valuation of the derivative liabilities on the convertible debt.

 

Net Profit (Loss):

 

Net profit (loss) for the three months ended September 30, 2022 was $297,961 compared with $(1,518,878) for the three months ended September 30, 2021. The increased profit can be explained by the gains on debt forgiveness and the change in fair value of derivative liabilities.

 

Results for the Nine Months Ended September 30, 2022 Compared to the Nine Months Ended September 30, 2021

 

Revenues:

 

The Company’s revenues were $1,102,141 for the nine months ended September 30, 2022 compared to $637,143 for the nine months ended September 30, 2021. The increase is due to a project in the amount of $957,344 being completed and delivered to BrewBilt Brewing in the second quarter of 2022.

 

Cost of Sales:

 

The Company’s cost of materials was $778,325 for the nine months ended September 30, 2022, compared to $373,544 for the nine months ended September 30, 2021. The increase is due to the BrewBilt Brewing job completed in Q2 2022.

 

Operating Expenses:

 

Operating expenses consisted primarily of consulting fees, professional fees, salaries and wages, office expenses and fees associated with preparing reports and SEC filings relating to being a public company. Operating expenses for the nine months ended September 30, 2022, and September 30, 2021, were $1,401,918 and $1,113,985, respectively. The increase is due to and increase in consulting fees, general and administrative expenses and wages.

 

Other Expense:

 

Other expense for the nine months ended September 30, 2022 and September 30, 2021 was $3,008,597 and $4,866,417, respectively. Other expense consisted of losses on derivative valuation, losses on conversion on preferred stock to common stock and interest expense. The gain or loss on derivative valuation is directly attributable to the change in fair value of the derivative liability. Interest expense is primarily attributable the initial interest expense associated with the valuation of derivative instruments at issuance and the accretion of the convertible debentures over their respective terms. The increase primarily resulted from a decrease in losses on conversion of debt and the fluctuation of the Company’s stock price which impacted the valuation of the derivative liabilities on the convertible debt.

26

 

Net Loss:

 

Net loss for the nine months ended September 30, 2022 was $4,086,699 compared with $5,716,803 for the nine months ended September 30, 2021. The decreased loss can be explained by the decrease in other expenses.

 

Liquidity and Capital Resources

 

The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As of September 30, 2022, the Company has a shareholders’ deficit of $14,640,699 since its inception, working capital deficit of $2,473,922, negative cash flows from operations, and has limited business operations, which raises substantial doubt about the Company’s ability to continue as going concern. The ability of the Company to meet its commitments as they become payable is dependent on the ability of the Company to obtain necessary financing or achieving a profitable level of operations. There is no assurance the Company will be successful in achieving these goals.

 

   September 30, 2022   December 31, 2021 
   $   $ 
Current Assets   2,206,040    1,318,748 
Current Liabilities   4,679,962    4,404,654 
Working Capital (Deficit)   (2,473,922)   (3,085,906)

 

The overall working capital (deficit) decreased from $(3,085,906) at December 31, 2021 to $(2,473,922) at September 30, 2022 due to an increase in accounts receivable and prepaid expenses and a decrease in derivative liabilities.

 

The Company requires additional capital to fully execute its marketing program and increase revenues. There can be no assurance that continued funding will be available on satisfactory terms. We intend to raise additional capital through the sale of equity, loans, or other short-term financing options.

 

   September 30, 2022   September 30, 2021 
   $   $ 
Cash Flows from (used in) Operating Activities   (537,491)   (632,364)
Cash Flows from (used in) Investing Activities       (156,304)
Cash Flows from (used in) Financing Activities   356,263    991,704 
Net Increase (decrease) in Cash During Period   (181,228)   203,036 

 

During the nine months ended September 30, 2022, cash from (used in) operating activities was $(537,491) compared to $(632,364) for the nine months ended September 30, 2022. The variance primarily resulted from the change in fair value of derivative liabilities, and an increase in operating assets during the nine months ended September 30, 2022.

 

During the nine months ended September 30, 2022, cash from (used in) investing activities was $0 compared to $(156,304) for the nine months ended September 30, 2021. The variance in cash from (used in) investing activity is due to a decrease in fixed assets purchases and disposals in the nine months ended September 30, 2022.

 

During the nine months ended September 30, 2022, cash from financing activities was $356,263 compared to $991,704 for the nine months ended September 30, 2021. The decrease in cash from financing activity is due to a decrease in proceeds from convertible debt and an increase in payments made to convertible debt during the nine months ended September 30, 2022.

 

Contractual Obligations

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

27

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

 

Critical Accounting Policies and Estimates

 

The preparation of our financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments which are based on historical experience and on various other factors that are believed to be reasonable under the circumstances. The results of their evaluation form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions and circumstances. Our significant accounting policies are more fully discussed in the Notes to our Financial Statements, included herein.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

A smaller reporting company is not required to provide the information required by this Item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Management’s Report on Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our president and chief financial officer (our principal executive officer, principal financial officer and principal accounting officer) to allow for timely decisions regarding required disclosure.

 

As of the end of the quarter covered by this report, we carried out an evaluation, under the supervision and with the participation of our president and chief financial officer (our principal executive officer, principal financial officer, and principal accounting officer), of the effectiveness of the design and operation of our disclosure controls and procedures. Based on the foregoing, our president and chief financial officer (our principal executive officer, principal financial officer, and principal accounting officer) concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this quarterly report. Our company is in the process of adopting specific internal control mechanisms to ensure effectiveness as we grow, and we will work to retain additional qualified individuals to ensure a proper segregation of duties. We have engaged an outside consultant to assist in adopting new measures to improve upon our internal controls. Future controls, among other things, will include more checks and balances and communication strategies between the management and the board, once we are able to secure additional board members, to ensure efficient and effective oversight over company activities as well as more stringent accounting policies to track and update our financial reporting.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the quarterly period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

28

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

We know of no material, existing or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers, or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our company.